Test Price
2,800 AED✅ Home Collection Available
GBE1 Gene Glycogen Storage Disease Type IV Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Complimentary Telephonic Post-Test Clinical Guidance in result interpretation with a DHA-licensed physician.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731 before any payment.
Test Overview & Methodology
A definitive genetic test analyzing the entire GBE1 gene via Next-Generation Sequencing (NGS) to diagnose Glycogen Storage Disease Type IV (Andersen disease), a rare metabolic disorder causing abnormal glycogen accumulation in the liver, heart, and muscles. Recommended by clinical geneticists for confirmatory diagnosis, pediatric metabolic specialists for early intervention planning, and primary care physicians for family screening and proactive management.
The test uses advanced sequencing technology to detect single nucleotide variants, small insertions/deletions, and splice-site mutations across the entire GBE1 coding region and exon-intron boundaries. Results are interpreted by a board-certified medical geneticist and integrated with clinical findings to guide targeted management and family cascade testing.
| Feature | Our UAE Premium NGS Test | Closest Alternative (Enzyme Assay/Biopsy) |
|---|---|---|
| Technology | Next-Generation Sequencing (NGS), full gene coverage | Biochemical enzyme activity (biopsy) or limited PCR panel |
| Diagnostic Sensitivity | >99.9% (ISO‑15189 validated) | ~75–85%, may miss regulatory mutations |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks (biopsy culture often required) |
| Sample Collection | Painless blood draw or FTA card (home collection available) | Invasive liver biopsy or muscle biopsy |
| Clinical Actionability | Identifies exact mutation for tailored monitoring & family cascade testing | Broad enzymatic deficiency without genetic granularity |
Physician Insight & Safety Protocols
“A genetic diagnosis can feel daunting, but knowledge is your family’s strongest shield. This NGS test offers precise clarity to tailor nutritional and medical strategies, helping you take informed, proactive steps. Remember, I am here to guide you through every result — you are never alone on this journey.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Pre-Test Preparation
- A mandatory genetic counselling session to draw a pedigree chart of family members affected with Glycogen Storage Disease Type IV.
- No fasting required unless otherwise instructed; continue prescribed medications unless your doctor advises otherwise.
- Please disclose any recent blood transfusions, as they may interfere with DNA extraction (consult our specialists).
Exclusion Criteria & Emergency Red Flags
Exclusion Criteria: This elective test is not suitable for patients who have not undergone genetic counseling, are unable to provide informed consent, or are currently in acute metabolic crisis.
Seek immediate medical help (call 998 or visit ER) if you experience:
- Severe abdominal distension with vomiting or jaundice
- Progressive muscle weakness causing difficulty breathing or swallowing
- Unexplained seizures or loss of consciousness
Patient FAQ & Clinical Guidance
1. What is the purpose of the GBE1 gene test and what does a positive result mean?
The GBE1 gene test uses Next-Generation Sequencing to detect pathogenic mutations causing Glycogen Storage Disease Type IV, enabling accurate diagnosis and family risk stratification. A positive result confirms the genetic basis of the disease, guiding liver, cardiac, and neurologic surveillance. Genetic counseling will explain inheritance patterns and help cascade testing for at-risk relatives.
2. Is home sample collection available and how does the cold-chain process work?
Yes, our DHA-licensed mobile phlebotomy team will visit your home between 8 AM and 11 PM for a sterile blood draw or FTA card collection, with every sample transported in ISO-certified cold-chain conditions. This ensures DNA stability from your doorstep to our lab. No special preparation is needed; simply coordinate your preferred time via WhatsApp. Results are securely delivered electronically.
3. Do I need insurance approval before the test and how is billing handled?
We provide a complimentary direct billing verification service via WhatsApp at +971545488731, so you will know your exact coverage and any out-of-pocket cost before the blood draw. Most major UAE insurers cover genetic testing for clinically suspected metabolic disorders when accompanied by a physician’s referral. Our team swiftly handles pre-authorization to minimize delays.
UAE Regulatory & Data Privacy Adherence
- Facility License: DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE
- Data Privacy: All genetic data is protected under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Clinical Safety: Patient consent and test safety are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Quality: ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139). Laboratory procedures follow ISO 15189:2024 standards.
- Medical Disclaimer: This page provides health information and does not replace a licensed physician’s advice. Results must be interpreted by a DHA-licensed geneticist.
- Contact: WhatsApp & Phone +971 54 548 8731
Clinical & Logistical Metadata
| Test Name | GBE1 Gene Glycogen Storage Disease Type IV Genetic Test (NGS) |
| Price (AED) | 2,800 |
| Turnaround Time | 3-4 weeks |
| Sample Type / Matrix | Whole blood (EDTA) or FTA card – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection |
| Methodology Used | Next-Generation Sequencing (NGS) – full gene sequencing of GBE1 |
| ICD-10-CM Code | E74.09 |
| LOINC Code | 50397-9 |
| DHA Facility License & Laboratory Address Invariants | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians